Home > Coronavirus vaccine: UK signs new deal for 60 million doses of potential COVID-19 solution

News
Coronavirus vaccine: UK signs new deal for 60 million doses of potential COVID-19 solution

Description

The world’s wealthiest countries are pre-ordering hundreds of millions of doses of potential vaccines – but there is no certainty any of them will effectively protect against COVID-19.

Added on the 29/07/2020 18:03:28 - Copyright : Euronews EN

To customise your video :

Or Create an account

More videos on the subject

  • Israel begins giving third Covid-19 vaccine doses to adults over 60

    Jerusalem, Aug 1 (EFE / EPA) .- Israel began Sunday to inject the third dose of the Covid-19 vaccine to adults over 60 years of age, after starting this inoculation phase on Friday with President Isaac Herzog and a small number of people.(Camera: ATEF SAFADI)SHOT LIST: VACCINATION DRIVE FOR THE THIRD JAB FOR ADULTS OVER 60 IN JERUSALEM, ISRAEL.

    02/08/2021 - EFE Inglés
  • Russia signs deal with India to produce 100 million Sputnik V annual doses

    Moscow, Apr 5 (EFE), (Camera EPA/EFE Archive).- The Russian Direct Investment Fund on Monday announced an agreement with the Indian Panacea Biotec to produce 100 million annual doses of the Sputnik V coronavirus vaccine.The deal would allow RDIF to provide its international partners with the jab, the Russian sovereign fund said in a statement.India is one of the first countries Russia has approached to manufacture the vaccine, approved by 59 countries.ARCHIVE FOOTAGE OF MOSCOW AND COVID-19VACCINATION IN INDIA.

    05/04/2021 - EFE Inglés
  • UK administers more than 5 million covid vaccine doses

    London (United Kingdom), Jan 21 (EFE), (Camera: Clàudia Sacrest).- The United Kingdom reported Thursday that it has already administered more than five million doses of the vaccine against covid-19 since it began its immunization campaign in early December.FOOTAGE OF THE LONDON BRIDGE CENTRE 1 VACCINATION CENTER, AND GUY'S HOSPITAL IN CENTRAL LONDON.

    21/01/2021 - EFE Inglés
  • Fosun Pharma, BioNTech to supply China with 100 million doses of Covid-19 vaccine

    Shanghai, Jan 4 (EFE/EPA).- Fosun Pharma, a Chinese listed pharmaceutical company, and Germany's BioNTech reported in December that they would supply Mainland China with 100 million doses of a COVID-19 vaccine in 2021, after regulatory approval. In March 2020, Shanghai-based pharmaceutical company Fosun Pharma made a purchase agreement with BioNTech to buy 50 million USD worth of stock. It became a strategic partner in developing and producing the mRNA vaccine. (Camera: ALEX PLAVEVSKI).SHOT LIST: THE FOSUN PHARMA HEADQUARTERS BUILDING IN SHANGHAI, CHINA.

    04/01/2021 - EFE Inglés
  • Pfizer Makes Deal For 100-Million Doses Of Vaccine

    On Wednesday, Pfizer and BioNTech announced having reached a deal with the U.S. government with an additional 100 million doses by July 31. That's up from the initial 100 million doses ordered already. The deal follows a similar extension of doses reached by the U.S. with Moderna for their vaccine. Both vaccines require two doses to be administered. The $2 billion deal calls for at least an additional 70 million doses to be provided to the U.S. by June 30. The remaining 30 million doses needing to be delivered by July 31. It also allows for the U.S. to obtain up to an additional 400 million doses in the future.

    23/12/2020 - Wochit

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32